IB

Indumati Bonthu

Director Director DIN 02299710
DIN 02299710 First appointment Sep 2008 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Indumati Bonthu

Data last updated:

Indumati Bonthu was a Director at Fugen Laboratories Private Limited (2008–2021) and Director at Cistra Pharma Laboratories Private Limited (from 2018). The companies operate in Pharma.

DIN 02299710
Primary Designation Director
Industry Pharma
First Appointment 06 Sep 2008
Oldest Company Age 21 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Fugen Laboratories Private Limited U24231TG2005PTC045207
Director06 Sep 20082005₹91.8 Lakh (FY 2021)Active
Director20 Apr 20182005Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cistra Pharma Laboratories Private Limited
Fugen Laboratories Private Limited
Premium access

Shareholding and investment profile for Indumati Bonthu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Indumati Bonthu

Indumati Bonthu was first appointed on 06 Sep 2008 as Director at Fugen Laboratories Private Limited. The most recent appointment on record is 20 Apr 2018 at Cistra Pharma Laboratories Private Limited.

Indumati Bonthu held 2 earlier board appointments: Fugen Laboratories Private Limited (Director, 06 Sep 2008 to 21 Jan 2021); Cistra Pharma Laboratories Private Limited (Director, from 20 Apr 2018).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available